Group items matching

in title, tags, annotations or url

UK-based consumer health company Kenvue has developed a series of tools and materials to support healthcare professionals - including pharmacy teams - with their conversations with smokers on their quit journey. This is part of their newly launched Smokefree Families initiative, which aims to help reduce the number of smoking households with children in England. Kenvue believes that pharmacists and their teams are vital to the success of this initiative, as they play a crucial role in supporting smokers in their quit journey. "As trusted sources of support and advice to families across the country, we firmly believe that community pharmacy teams are crucial to the success of our Smokefree Families initiative," Manoj Raghunandanan, Area Managing Director, Northern Europe at Kenvue, told Pharmacy Business. "To support them, we've created a series of tools and materials that can help pharmacists and other healthcare professionals tackle sensitive conversations with new and expectant parents, their partners and support networks, and ultimately motivate them on their quit journey."

People are advised to be mindful of medications that may cause sun reactions, and to watch out for dodgy hay fever treatments and fake weight loss pens. For those traveling abroad, the MHRA advises considering the suitability of medicines available to reduce the risk of contracting tropical diseases. Dr Alison Cave, Chief Safety Officer at the MHRA, said: "The summer is an exciting time for many of us, as we take time off to travel and enjoy the warmer weather. "But it is important to understand what this time of year means for our medicines and medical devices, and take the precautions necessary to use products safely and protect ourselves." Watch out for dodgy hay fever treatments Millions of Britons suffer from hay fever symptoms in the summer. The MHRA advises consulting a healthcare professional to find the best treatment for your symptoms. People are also warned to be cautious of medicines advertised as hay fever treatments but not approved for use in the UK, such as Kenalog. This is a prescription-only steroid injection licensed as a medicine for other conditions, but not for the treatment of hay fever.